Search | TVST | ARVO Journals

Showing 1 – 20 of 159

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Real-world clinical and anatomical outcomes in patients with neovascular age-related macular degeneration (nAMD) treated with faricimab: The FARETINA-AMD study

David Tabano; Stella Ko; Durga Borkar; Theodore Leng; Ferhina Ali; Jacqueline K. Shaia; Rachel Myers; Andrew LaPrise; Rishi P Singh

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2113.

Clinical and Epidemiologic Research May 2024

Intraretinal Hyper-Reflective Foci Are Almost Universally Present and Co-Localize With Intraretinal Fluid in Diabetic Macular Edema

PDF

Esther L. von Schulthess; Andreas Maunz; Usha Chakravarthy; Nancy Holekamp; Daniel Pauleikhoff; Katie Patel; Isabel Bachmeier; Siqing Yu; Yaniv Cohen; Mahnaz Parian Scherb; Ian L. Jones; Kara Gibson; Jeffrey R. Willis; Carl Glittenberg; Rishi P. Singh; Sascha Fauser
TAGS: diabetic macular edema, face, retina, severity of illness, spectral domain-optical coherence tomography, volume
Invest. Ophthalmol. Vis. Sci.. 2024; 65(5):26. https://doi.org/10.1167/iovs.65.5.26

Includes: Supplemental Content

Retina June 2023

High Variation in Inner Retinal Reflectivity Predicts Poor Visual Outcome in Patients With Central Retinal Vein Occlusion: SCORE2 Report 21

PDF

Nitish Mehta; Sachi Patil; Vikram Modi; Rachel Vardi; Kevin Liu; Rishi P. Singh; David Sarraf; Neal L. Oden; Paul C. VanVeldhuisen; Ingrid U. Scott; Michael S. Ip; Barbara A. Blodi; Yasha Modi
TAGS: central retinal vein occlusion, vision, spectral domain-optical coherence tomography, patient prognosis, macular edema, trees (plant)
Trans. Vis. Sci. Tech.. 2023; 12(6):21. https://doi.org/10.1167/tvst.12.6.21

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2023

Lower incidence of ocular pathology following bariatric surgery for morbid obesity across a large United States National Database.

Matthew W Russell; Madhukar Kumar; Ang Li; Rishi P Singh; Katherine Talcott

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1158.

ARVO Annual Meeting Abstract June 2023

Long-Term Functional and Anatomical Outcomes of Early and Limited Responders to Anti-VEGF in Retinal Vein Occlusion

Roshni Sarasi Kailar; Scott W. Perkins; Blanche L. Kuo; Rishi P Singh

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1781.

ARVO Annual Meeting Abstract June 2023

The incidence, time to development, and risk factors for fellow eye retinal vein occlusions

Brian James Liu; Jacqueline K. Shaia; Kevin Allan; Blanche L. Kuo; Rishi P Singh; Katherine Talcott

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1773.

ARVO Annual Meeting Abstract June 2023

FARETINA-AMD- Early Treatment Patterns and Outcomes in Patients with Neovascular Age-Related Macular Degeneration Initiating Faricimab: an IRIS Registry TM Analysis

Durga S Borkar; David Tabano; Vincent Garmo; Jacqueline K. Shaia; Blanche Kuo; Rachel Myers; Andrew LaPrise; Theodore Leng; Rishi P Singh

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2218.

ARVO Annual Meeting Abstract June 2023

Long-term outcomes in eyes with early residual fluid in neovascular age-related macular degeneration

Karina Else Pedersen; Anna K Wu; Christopher Maatouk; Rishi P Singh

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2197.

ARVO Annual Meeting Abstract June 2023

Prevalence of Geographic Atrophy as assessed by Optical Coherence Tomography in Patients with Intermediate Age-Related Macular Degeneration

Aleksandra Rachitskaya; Andrei Szigiato; Christopher Maatouk; Katherine Talcott; Rishi P Singh

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2155.

ARVO Annual Meeting Abstract June 2023

FARETINA-DME- Early Treatment Patterns and Outcomes in Patients with Diabetic Macular Edema Treated with Faricimab: an IRIS Registry TM Analysis

David Tabano; Durga S Borkar; Vincent Garmo; Jacqueline K. Shaia; Blanche Kuo; Rachel Myers; Andrew LaPrise; Theodore Leng; Rishi P Singh

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2699.

ARVO Annual Meeting Abstract June 2023

Baseline Factors Influencing Resolution of Diabetic Macular Edema (DME) Following Treatment with Intravitreal Dexamethasone Implant in the MEAD Study

Katherine Talcott; Carolina Carvalho Soares Valentim; Hongxin Lai; Miller J Ogidigben; Rishi P Singh

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2639.

ARVO Annual Meeting Abstract June 2023

Characterization of Sustained Increases in Intraocular Pressure After Aflibercept in Prefilled and Vial Draw Syringes.

Neil Akash Rana; Matthew W Russell; Meghana Chalasani; Justin Muste; Rishi P Singh; Sumit Sharma

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2706.

ARVO Annual Meeting Abstract June 2023

Predictors of visual response after lapse in anti-VEGF treatment among patients with diabetic retinopathy

Meghana Chalasani; Christopher Maatouk; Rishi P Singh; Katherine Talcott

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2696.

ARVO Annual Meeting Abstract June 2023

Opioid Prescription Characterization After Ocular Procedures in a Large US Cohort

Jacqueline K. Shaia; Sachin Singh; Rishi P Singh; Katherine Talcott

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3028.

ARVO Annual Meeting Abstract June 2023

CALM: A retrospective registry to characterize clinical outcomes for chronic non-infectious posterior segment uveitis patients treated with the 0.18 mg fluocinolone acetonide intravitreal insert: Intraocular Pressure and Safety Data Analysis

Kanika Seth; Alison Zhao; Rishi P Singh; Sumit Sharma

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3552.

ARVO Annual Meeting Abstract June 2023

Real-world predictive factors for the resolution of diabetic macular edema (DME)

Kristie J Sun; Samuel Harwood; Bridger Jeppesen; Urvi Gupta; Christopher Maatouk; Anna K Wu; Carolina Carvalho Soares Valentim; Katherine Talcott; Rishi P Singh

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2710.

ARVO Annual Meeting Abstract June 2023

Associations Between Lipid Abnormalities and Diabetic Retinopathy

Hejin Jeong; Christopher Maatouk; Matthew W Russell; Rishi P Singh

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2268.

ARVO Annual Meeting Abstract June 2023

Characterization and Progression of Diabetic Retinopathy During Pregnancy

Jason Matthew Singer; Kanika Seth; Neil Akash Rana; Katherine Talcott; Rishi P Singh

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2295.

ARVO Annual Meeting Abstract June 2023

Predictors of Response to a Lapse in Anti-VEGF Treatment in Patients with Macular Edema Secondary to Retinal Vein Occlusions

Christopher Maatouk; Jessica C Liu; Peter Alsaloum; Amogh Iyer; Peter Kaiser; Rishi P Singh; Katherine Talcott

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1790.

ARVO Annual Meeting Abstract June 2023

CALM: 12-month results from a real-world registry to characterize clinical outcomes for patients with chronic non-infectious posterior segment uveitis treated with a 0.18 mg fluocinolone acetonide intravitreal insert

Stephen Anesi; Peter Yuwei Chang; Rishi P Singh; Sumit Sharma

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):5097.

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Real-world clinical and anatomical outcomes in patients with neovascular age-related macular degeneration (nAMD) treated with faricimab: The FARETINA-AMD study

Intraretinal Hyper-Reflective Foci Are Almost Universally Present and Co-Localize With Intraretinal Fluid in Diabetic Macular Edema

High Variation in Inner Retinal Reflectivity Predicts Poor Visual Outcome in Patients With Central Retinal Vein Occlusion: SCORE2 Report 21

Lower incidence of ocular pathology following bariatric surgery for morbid obesity across a large United States National Database.

Long-Term Functional and Anatomical Outcomes of Early and Limited Responders to Anti-VEGF in Retinal Vein Occlusion

The incidence, time to development, and risk factors for fellow eye retinal vein occlusions

FARETINA-AMD- Early Treatment Patterns and Outcomes in Patients with Neovascular Age-Related Macular Degeneration Initiating Faricimab: an IRIS Registry TM Analysis

Long-term outcomes in eyes with early residual fluid in neovascular age-related macular degeneration

Prevalence of Geographic Atrophy as assessed by Optical Coherence Tomography in Patients with Intermediate Age-Related Macular Degeneration

FARETINA-DME- Early Treatment Patterns and Outcomes in Patients with Diabetic Macular Edema Treated with Faricimab: an IRIS Registry TM Analysis

Baseline Factors Influencing Resolution of Diabetic Macular Edema (DME) Following Treatment with Intravitreal Dexamethasone Implant in the MEAD Study

Characterization of Sustained Increases in Intraocular Pressure After Aflibercept in Prefilled and Vial Draw Syringes.

Predictors of visual response after lapse in anti-VEGF treatment among patients with diabetic retinopathy

Opioid Prescription Characterization After Ocular Procedures in a Large US Cohort

CALM: A retrospective registry to characterize clinical outcomes for chronic non-infectious posterior segment uveitis patients treated with the 0.18 mg fluocinolone acetonide intravitreal insert: Intraocular Pressure and Safety Data Analysis

Real-world predictive factors for the resolution of diabetic macular edema (DME)

Associations Between Lipid Abnormalities and Diabetic Retinopathy

Characterization and Progression of Diabetic Retinopathy During Pregnancy

Predictors of Response to a Lapse in Anti-VEGF Treatment in Patients with Macular Edema Secondary to Retinal Vein Occlusions

CALM: 12-month results from a real-world registry to characterize clinical outcomes for patients with chronic non-infectious posterior segment uveitis treated with a 0.18 mg fluocinolone acetonide intravitreal insert

To View More...

You must be signed into an individual account to use this feature.